Thiamine-responsive anemia in DIDMOAD syndrome

C Borgna-Pignatti, P Marradi, L Pinelli, N Monetti… - The Journal of …, 1989 - Elsevier
C Borgna-Pignatti, P Marradi, L Pinelli, N Monetti, C Patrini
The Journal of pediatrics, 1989Elsevier
Two children with DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy,
deafness) developed a megaloblastic and sideroblastic anemia, neutropenia, and
borderline thrombocytopenia. Plasma thiamine concentration was low in one patient and
normal in the other; in both children, thiamine pyrophosphate in erythrocytes and thiamine
pyrophosphokinase activity were lower than the lowest values observed in control subjects.
A month after institution of treatment with thiamine, the hematologic findings had returned to …
Two children with DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, deafness) developed a megaloblastic and sideroblastic anemia, neutropenia, and borderline thrombocytopenia. Plasma thiamine concentration was low in one patient and normal in the other; in both children, thiamine pyrophosphate in erythrocytes and thiamine pyrophosphokinase activity were lower than the lowest values observed in control subjects. A month after institution of treatment with thiamine, the hematologic findings had returned to normal and the insulin requirements had decreased. Withdrawal of thiamine repeatedly induced relapse of the anemia and an increase in insulin requirements. We propose that an inherited abnormality of thiamine metabolism is responsible for the multisystem degenerative disorder known as DIDMOAD syndrome.
Elsevier